George R. Simon

11.8k citations

234 papers · 7.6k indexed · 1 hit paper · h-index 47

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers

Papers in

Pulmonary and Respiratory Medicine 155
- Lung Cancer Treatments and Mutations 95
- Lung Cancer Diagnosis and Treatment 41
- Pleural and Pulmonary Diseases 19
Oncology 92
- Lung Cancer Research Studies 40
- Cancer Immunotherapy and Biomarkers 21
- Colorectal Cancer Treatments and Studies 21

Co-authors: Gerold Bepler Alan Cantor Lynne Reid Alberto Chiappori Swati Sharma Scott Antonia Andrew T. Turrisi Henry R. Wagner
Journals: Journal of Clinical Oncology (50 papers)Journal of Thoracic Oncology (20 papers)Thorax (14 papers)Clinical Radiology (11 papers)Clinical Cancer Research (10 papers)
Partner nations: United States United Kingdom France

In The Last Decade

George R. Simon

223 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials 2020 · 353 citations

Peers

Countries citing papers authored by George R. Simon

Since Specialization

Citations

This map shows the geographic impact of George R. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George R. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George R. Simon more than expected).

Fields of papers citing papers by George R. Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George R. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George R. Simon. The network helps show where George R. Simon may publish in the future.

Co-authors

The 25 scholars most cited alongside George R. Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with George R. Simon Line = papers co-authored together George R. Simon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial Nature Communications ·Jeffrey Clarke, George R. Simon, Hirva Mamdani, Lin Gu, James E. Herndon, Thomas E. Stinchcombe, Neal Ready, Jeffrey Crawford, Guru Sonpavde, Stephen J. Balevic, Andrew B. Nixon, Michael J. Campa, Elizabeth B. Gottlin, Huihua Li, Ruchi Saxena, You‐Wen He, Scott Antonia, Edward F. Patz	2025	7
2	PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017–2021 PubMed ·Mehmet Altan, Dawen Sui, Cai Xu, George R. Simon, Saliha T. Sulihem, Donna Malveaux, Darcy Ponce, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Jianjun Zhang, Don L. Gibbons, Ara A. Vaporciyan, John V. Heymach, Melissa L. Santorelli, Thomas W. Burke, Loretta A. Williams	2025	1
3	Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non–Small Cell Lung Cancer JCO Precision Oncology ·Jeanna Wallenta Law, Bela Bapat, Connor Sweetnam, Hina Mohammed, Ashleigh E. McBratney, Monika A. Izano, Molly Scannell Bryan, Scott Spencer, Brock E. Schroeder, Damon Hostin, George R. Simon, Anna B. Berry	2024	7
4	Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer JNCI Cancer Spectrum ·Molly Scannell Bryan, Xiaohan Hu, Monika A. Izano, Hina Mohammed, Mark S. Wicks, Thomas D. Brown, George R. Simon, Henry G. Kaplan, Anna B. Berry	2024	0
5	Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation Journal of Thoracic Disease ·Sophia Gilardone, Ram Thapa, José Laborde, Michael Shafique, Andreas Saltos, Ben Creelan, Tawee Tanvetyanon, Alberto Chiappori, George R. Simon, Eric B. Haura, Jhanelle E. Gray, Dung‐Tsa Chen, Daniel J. Melzer, Bruna Pellini	2023	4
6	OA13.01 S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma Journal of Thoracic Oncology ·Anne S. Tsao, Liya Qian, Jeremy Cetnar, Boris Sepesi, Daniel R. Gomez, John Wrangle, George R. Simon, Frank E. Mott, Richard D. Hall, Rafael Santana-Dávila, Marianna Koczywas, Mary W. Redman, Karen Kelly	2021	7
7	What Do Patients With Non–Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer JCO Oncology Practice ·Meagan Whisenant, Loretta A. Williams, Araceli García-González, Tito R. Mendoza, Qiuling Shi, Charles S. Cleeland, Jianjun Zhang, John V. Heymach, George R. Simon	2020	13
8	MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC) Journal of Thoracic Oncology ·Loretta A. Williams, Qiuling Shi, Belqis El Ferjani, M. Hirschmann, Darcy Ponce, Seyedeh Dibaj, Sheenu Chandwani, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Thomas Burke, Charles S. Cleeland, Jes Chauviere Lee, Jack A. Roth, S. Swisher, John V. Heymach, J. Zhang, George R. Simon	2019	1
9	Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials Lung Cancer ·Hossein Maymani, Kenneth R. Hess, Roman Groisberg, David S. Hong, Aung Naing, Sarina A. Piha‐Paul, Filip Jankú, Siqing Fu, Apostolia M. Tsimberidou, Shubham Pant, Daniel D. Karp, Shuang Liu, Ming Sun, John V. Heymach, George R. Simon, Funda Meric‐Bernstam, Vivek Subbiah	2018	27
10	P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer Journal of Thoracic Oncology ·Loretta A. Williams, Shiva Dibaj, Sheenu Chandwani, Viralkumar Vaghani, Qiuling Shi, M. Hirschmann, L.L. Landry, Emily Roarty, J. Zhang, W. Rinsurnogkawong, Jeffery D. Lewis, Thomas Burke, Charles S. Cleeland, Jes Chauviere Lee, Jack A. Roth, S. Swisher, John V. Heymach, George R. Simon	2018	1
11	Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations Cancer Research ·Erick Riquelme, Carmen Behrens, Heather Lin, George R. Simon, Vassiliki A. Papadimitrakopoulou, Julie Izzo, César A. Moran, Neda Kalhor, J. Jack Lee, John D. Minna, Ignacio I. Wistuba	2015	85
12	VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy Clinical Cancer Research ·Erick Riquelme, Milind Suraokar, Carmen Behrens, Heather Lin, Luc Girard, Monique B. Nilsson, George R. Simon, Jing Wang, Kevin R. Coombes, J. Jack Lee, Waun Ki Hong, John V. Heymach, John D. Minna, Ignacio I. Wistuba	2014	59
13	EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma Clinical Cancer Research ·Carmen Behrens, Luisa M. Solis, Heather Lin, Ping Yuan, Ximing Tang, Humam Kadara, Erick Riquelme, Héctor Galindo, César A. Moran, Neda Kalhor, Stephen G. Swisher, George R. Simon, David J. Stewart, J. Jack Lee, Ignacio I. Wistuba	2013	123
14	A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer Clinical Cancer Research ·David S. Hong, Razelle Kurzrock, Yun Oh, Jennifer J. Wheler, Aung Naing, Les Brail, Sophie Callies, Valérie André, Sunil Kadam, Aejaz Nasir, Timothy R. Holzer, Funda Meric‐Bernstam, Mayer Fishman, George R. Simon	2011	113
15	Molecular Targeted Therapy in Non-small Cell Lung Cancer: An Overview of Available Agents Journal of Thoracic Oncology ·Neeta Somaiah, George R. Simon	2009	2
16	Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·George R. Simon, Anupama Sharma, Xueli Li, Todd R. Hazelton, Frank Walsh, Charles C. Williams, Alberto Chiappori, Eric B. Haura, Tawee Tanvetyanon, Scott Antonia, Alan Cantor, Gerold Bepler	2007	147
17	Evidence for Management of Small Cell Lung Cancer CHEST Journal ·David J Samson, Jerome Seidenfeld, George R. Simon, Andrew T. Turrisi, Claudia J Bonnell, Kathleen M Ziegler, Naomi Aronson	2007	49
18	X-ray diagnosis for clinical students George R. Simon	1975	5
19	The value of radiology in critical mitral stenosis Clinical Radiology ·George R. Simon	1964	5
20	MUCOVISCIDOSIS AND ADULT CHRONIC BRONCHITIS The Lancet ·D. C. F. Muir, John Batten, George R. Simon	1962	3

About George R. Simon

George R. Simon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Microbiology and Biotechnology, having authored 234 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (95 papers), Lung Cancer Diagnosis and Treatment (41 papers), Lung Cancer Research Studies (40 papers), Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (21 papers), Colorectal Cancer Treatments and Studies (21 papers), Pleural and Pulmonary Diseases (19 papers) and RNA modifications and cancer (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Oncology (3.1k citations), Cancer Research (972 citations), Molecular Biology (2.5k citations) and Immunology (642 citations). George R. Simon has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Gerold Bepler, Alan Cantor, Lynne Reid, Alberto Chiappori, Swati Sharma, Scott Antonia, Andrew T. Turrisi, Henry R. Wagner, Charles C. Williams and Eric B. Haura. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Thorax, Clinical Radiology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact